Prevalence of iron deficiency in heart transplant recipients.

BACKGROUND

Optimal iron management is crucial to marginal patients such as heart transplant recipients. As inflammatory mechanisms are present in transplant recipients, the definition of iron deficiency used in the general population might not be appropriate.

OBJECTIVE

To evaluate the prevalence and determinants of iron deficiency in Norwegian heart transplant recipients.

METHODS

We consecutively assessed iron parameters in all Norwegian heart transplant recipients at their annual follow-up. Several definitions of iron deficiency suggested in the literature were assessed: ferritin <100 µg/L, or ferritin 100-300 µg/L combined with transferrin saturation of <20% (ID ); ferritin <100 µg/L (ID ); transferrin saturation of <20% (ID ), and ferritin <30 µg/L (ID ).

RESULTS

179 of 378 heart transplant recipients (47%) had iron deficiency defined as ID . 152 patients (40%) had ID , and 103 patients (27%) had ID . 17 patients (5%) had ID . 88 patients (23%) had a C-reactive protein (CRP) >5.0 µg/L.

CONCLUSION

Iron deficiency defined as ID , ID or ID is prevalent in the heart transplant population, while ID is not. Further research is required to identify the mechanisms of iron homeostasis in heart transplant recipients and to establish a definition of iron deficiency suitable for this population.